Saturday, October 29, 2016

Itraconazole


it-ra-KON-a-zole


Oral route(Capsule)

Itraconazole capsules should not be administered for the treatment of onychomycosis in patients with evidence of ventricular dysfunction such as congestive heart failure (CHF) or a history of CHF. If signs or symptoms of CHF occur during administration of itraconazole capsules, discontinue administration. Coadministration of cisapride, pimozide, quinidine, dofetilide, or levacetylmethadol (levomethadyl) with itraconazole is contraindicated. Itraconazole, a potent CYP3A4 inhibitor, may increase plasma concentrations of drugs metabolized by this pathway. Serious cardiovascular events, including QT prolongation, torsades de pointes, ventricular tachycardia, cardiac arrest, and/or sudden death have occurred in patients using cisapride, pimozide, levacetylmethadol (levomethadyl), or quinidine concomitantly with itraconazole and/or other CYP3A4 inhibitors .


Oral route(Solution)

If signs or symptoms of congestive heart failure occur during administration of itraconazole, continued itraconazole use should be reassessed. Coadministration of cisapride, pimozide, quinidine, dofetilide, or levacetylmethadol (levomethadyl) with itraconazole is contraindicated. Itraconazole, a potent CYP3A4 inhibitor, may increase plasma concentrations of drugs metabolized by this pathway. Serious cardiovascular events, including QT prolongation, torsades de pointes, ventricular tachycardia, cardiac arrest, and/or sudden death have occurred in patients using cisapride, pimozide, levacetylmethadol (levomethadyl), or quinidine concomitantly with itraconazole and/or other CYP3A4 inhibitors .



Commonly used brand name(s)

In the U.S.


  • Sporanox

Available Dosage Forms:


  • Solution

  • Capsule

Therapeutic Class: Antifungal


Chemical Class: Triazole


Uses For itraconazole


Itraconazole is used to treat serious fungal or yeast infections, such as oropharyngeal candidiasis (thrush, oral thrush), esophageal candidiasis (candida esophagitis), blastomycosis (Gilchrist’s disease), aspergillosis (fungal infection in the lungs), histoplasmosis (Darling’s disease), or onychomycosis (fungal infection in the fingernails or toenails). itraconazole works by killing the fungus or yeast and preventing its growth.


itraconazole is available only with your doctor's prescription.


Before Using itraconazole


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For itraconazole, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to itraconazole or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies on the relationship of age to the effects of itraconazole have not been performed in the pediatric population. Safety and efficacy have not been established. However, pediatric-specific problems that would limit the usefulness of itraconazole in children are not expected.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of itraconazole in the elderly. However, elderly patients are more likely to have temporary or permanent hearing loss, which may require caution in patients receiving itraconazole.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking itraconazole, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using itraconazole with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Alfuzosin

  • Alprazolam

  • Astemizole

  • Cisapride

  • Colchicine

  • Conivaptan

  • Dihydroergotamine

  • Dofetilide

  • Dronedarone

  • Eplerenone

  • Ergoloid Mesylates

  • Ergonovine

  • Ergotamine

  • Levomethadyl

  • Lovastatin

  • Methylergonovine

  • Methysergide

  • Midazolam

  • Nisoldipine

  • Pimozide

  • Quinidine

  • Ranolazine

  • Silodosin

  • Simvastatin

  • Terfenadine

  • Tolvaptan

  • Triazolam

Using itraconazole with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Abiraterone

  • Aliskiren

  • Amiodarone

  • Aprepitant

  • Atorvastatin

  • Boceprevir

  • Brentuximab Vedotin

  • Bretylium

  • Cabazitaxel

  • Cerivastatin

  • Clozapine

  • Crizotinib

  • Cyclosporine

  • Dasatinib

  • Diazepam

  • Digoxin

  • Disopyramide

  • Docetaxel

  • Efavirenz

  • Erythromycin

  • Etravirine

  • Everolimus

  • Fentanyl

  • Fluticasone

  • Halofantrine

  • Ibutilide

  • Iloperidone

  • Isoniazid

  • Ixabepilone

  • Lapatinib

  • Nevirapine

  • Nilotinib

  • Oxycodone

  • Pazopanib

  • Repaglinide

  • Rifabutin

  • Rifampin

  • Rivaroxaban

  • Romidepsin

  • Ruxolitinib

  • Salmeterol

  • Sirolimus

  • Sotalol

  • Sunitinib

  • Tacrolimus

  • Tadalafil

  • Tamsulosin

  • Temsirolimus

  • Ticagrelor

  • Toremifene

  • Vemurafenib

  • Venlafaxine

  • Vinblastine

  • Vincamine

  • Vincristine

  • Vincristine Liposome

  • Vindesine

  • Vinorelbine

Using itraconazole with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Acenocoumarol

  • Alfentanil

  • Aluminum Carbonate, Basic

  • Aluminum Hydroxide

  • Aluminum Phosphate

  • Amlodipine

  • Anisindione

  • Betamethasone

  • Bexarotene

  • Bortezomib

  • Budesonide

  • Buspirone

  • Busulfan

  • Calcium

  • Cinacalcet

  • Ciprofloxacin

  • Clarithromycin

  • Conjugated Estrogens

  • Corticotropin

  • Cosyntropin

  • Dexamethasone

  • Dicumarol

  • Didanosine

  • Dihydroxyaluminum Aminoacetate

  • Dihydroxyaluminum Sodium Carbonate

  • Esterified Estrogens

  • Estradiol

  • Estriol

  • Estrone

  • Estropipate

  • Famotidine

  • Felodipine

  • Fesoterodine

  • Fludrocortisone

  • Fosphenytoin

  • Gefitinib

  • Hydrocortisone

  • Indinavir

  • Isradipine

  • Loperamide

  • Magaldrate

  • Magnesium Carbonate

  • Magnesium Hydroxide

  • Magnesium Oxide

  • Magnesium Trisilicate

  • Meloxicam

  • Methadone

  • Methylprednisolone

  • Micafungin

  • Nicardipine

  • Nifedipine

  • Nimodipine

  • Pantoprazole

  • Phenobarbital

  • Phenprocoumon

  • Phenytoin

  • Prednisolone

  • Prednisone

  • Rabeprazole

  • Ranitidine

  • Ranitidine Bismuth Citrate

  • Rifapentine

  • Risperidone

  • Ritonavir

  • Rosuvastatin

  • Saquinavir

  • Sildenafil

  • Sodium Bicarbonate

  • Telithromycin

  • Tolterodine

  • Trazodone

  • Triamcinolone

  • Trimetrexate

  • Vardenafil

  • Verapamil

  • Warfarin

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using itraconazole with any of the following may cause an increased risk of certain side effects but may be unavoidable in some cases. If used together, your doctor may change the dose or how often you use itraconazole, or give you special instructions about the use of food, alcohol, or tobacco.


  • food

  • Grapefruit Juice

Other Medical Problems


The presence of other medical problems may affect the use of itraconazole. Make sure you tell your doctor if you have any other medical problems, especially:


  • Chronic obstructive pulmonary disease (COPD), history of or

  • Congestive heart failure, history of or

  • Heart problems (e.g., heart attack history, valve problem), history of or

  • Kidney disease, history of—Use with caution. May increase the risk for side effects.

  • Cystic fibrosis or

  • Hypochlorhydria (low level of acid in the stomach)—Absorption from the stomach may change.

  • Liver disease—Use with caution. The effects of itraconazole may be increased because of slower removal from the body.

  • Liver disease, severe—Use with caution. May make this condition worse.

Proper Use of itraconazole


Itraconazole oral solution works differently than itraconazole capsules, even at the same dose (number of milligrams). Do not switch from the capsules to the oral solution unless your doctor tells you to.


Keep using itraconazole for the full treatment time, even if you feel better after the first few doses. Your infection may not clear up if you stop using the medicine too soon.


itraconazole comes with a patient information leaflet. Read and follow the instructions in the leaflet carefully. Talk with your doctor if you have any questions.


Itraconazole capsules should be taken with a full meal. The oral solution is best taken on an empty stomach.


Measure the oral solution with a marked measuring spoon or medicine cup. If you have thrush in the mouth or throat, place 10 milliliters (mL) of the liquid in your mouth, swish it in the mouth for several seconds, and then swallow it. Repeat these steps if your total dose is more than 10 mL. If you do not have oral thrush, the liquid should be swallowed without swishing as a single dose.


If you are using antacids (e.g., Maalox®, Mylanta®, Pepcid® Complete, Rolaids®, or Tums®), take the antacid at least 1 hour before or 2 hours after taking itraconazole.


Dosing


The dose of itraconazole will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of itraconazole. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (capsules):
    • For aspergillosis:
      • Adults—200 to 400 milligrams (mg) per day, given as a single dose once a day or divided in two doses.

      • Children—Use and dose must be determined by your doctor.


    • For blastomycosis or histoplasmosis:
      • Adults—200 milligrams (mg) once a day. Your doctor may increase your dose if needed. However, the dose is usually not more than 400 mg per day.

      • Children—Use and dose must be determined by your doctor.


    • For onychomycosis of the fingernails:
      • Adults—200 milligrams (mg) two times a day.

      • Children—Use and dose must be determined by your doctor.


    • For onychomycosis of the toenails:
      • Adults—200 milligrams (mg) once a day.

      • Children—Use and dose must be determined by your doctor.



  • For oral dosage form (solution):
    • For esophageal candidiasis:
      • Adults—At first, 100 milligrams (mg) or 10 milliliters (mL) once a day. Your doctor may increase your dose if needed.

      • Children—Use and dose must be determined by your doctor.


    • For serious fungal infections:
      • Adults—200 milligrams (mg) or 20 milliliters (mL) two times a day.

      • Children—Use and dose must be determined by your doctor.


    • For oropharyngeal candidiasis:
      • Adults—200 milligrams (mg) or 20 milliliters (mL) once a day.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of itraconazole, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using itraconazole


It is very important that your doctor check your progress at regular visits to make sure that itraconazole is working properly and to check for unwanted effects.


If your symptoms do not improve, or if they become worse, check with your doctor. You may need to take itraconazole for several weeks or months before your infection gets better.


Stop using itraconazole and check with your doctor right away if you are having chest pain; decreased urine output; dilated neck veins; extreme fatigue; irregular breathing; an irregular heartbeat; shortness of breath; swelling of the face, fingers, feet, or lower legs; tightness in the chest; troubled breathing; weight gain; or wheezing. These could be symptoms of a side effect called congestive heart failure.


Itraconazole should not be taken with cisapride (Propulsid®), dofetilide (Tikosyn™), oral midazolam (Versed®), nisoldipine (Sular®), pimozide (Orap®), quinidine (Quinaglute®), triazolam (Halcion®), or levomethadyl (Orlaam®). You should not use itraconazole if you are also using lovastatin (Mevacor®), simvastatin (Zocor®), or an ergot medicine such as dihydroergotamine (Migranal®), ergometrine or ergonovine (Ergotrate Maleate®), ergotamine (Ergomar®), or methylergometrine or methylergonovine (Methergine®). Doing so may increase the risk of serious side effects.


Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.


Make sure your doctor knows if you are pregnant or planning to get pregnant before you start using itraconazole for a fingernail or toenail infection. The oral capsule should not be used to treat onychomycosis in pregnant women or those who are planning to get pregnant. Use an effective form of birth control while you are using itraconazole and for 2 months after you stop using it. If you think you have become pregnant while using the medicine, tell your doctor right away.


Liver problems may occur while you are taking itraconazole. Check with your doctor right away if you are having more than one of these symptoms: stomach pain or tenderness; clay-colored stools; dark urine; decreased appetite; fever; headache; itching; loss of appetite; nausea and vomiting; skin rash; swelling of the feet or lower legs; unusual tiredness or weakness; or yellow eyes or skin.


Stop using itraconazole and call your doctor right away if your skin feels like it is burning, crawling, itching, or if you have numbness, prickling, "pins and needles", or a tingling feeling after taking itraconazole.


Temporary or permanent hearing loss may occur while you are taking itraconazole. Stop using itraconazole and check with your doctor right away if you have any changes in your hearing.


itraconazole Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Convulsions

  • decreased urine

  • dry mouth

  • fever

  • increased thirst

  • irregular heartbeat

  • loss of appetite

  • mood changes

  • muscle pain or cramps

  • nausea or vomiting

  • numbness or tingling in the hands, feet, or lips

  • shortness of breath

  • unusual tiredness or weakness

Less common
  • Abdominal or stomach cramps

  • abdominal or stomach pain

  • blurred vision

  • chest pain

  • chills

  • clay-colored stools

  • cloudy urine

  • cold sweats

  • confusion

  • cough

  • dark urine

  • decrease in urine output or decrease in urine-concentrating ability

  • diarrhea

  • difficult or labored breathing

  • dizziness

  • dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly

  • drowsiness

  • feeling unusually cold

  • headache

  • itching

  • large amount of triglyceride in the blood

  • light-colored stools

  • mental changes

  • muscle cramps in the hands, arms, feet, legs, or face

  • muscle spasms (tetany) or twitching

  • nervousness

  • noisy, rattling breathing

  • numbness and tingling around the mouth or fingertips

  • pounding in the ears

  • rash

  • seizures

  • shivering

  • slow, fast, or pounding heartbeat or pulse

  • sneezing

  • sore throat

  • sweating

  • swelling of the fingers, hands, feet, or lower legs

  • tightness in the chest

  • trembling

  • troubled breathing at rest

  • unpleasant breath odor

  • vomiting of blood

  • weight gain

  • wheezing

  • yellow eyes or skin

Rare
  • Abdominal or stomach tenderness

  • black, tarry stools

  • bleeding gums

  • blistering, peeling, or loosening of the skin

  • bloating or swelling of the face, arms, hands, lower legs, or feet

  • blood in the urine or stools

  • blue lips and fingernails

  • burning, crawling, itching, numbness, painful, prickling, "pins and needles", or tingling feelings

  • continuing ringing or buzzing or other unexplained noise in the ears

  • coughing that sometimes produces a pink frothy sputum

  • cracks in the skin

  • decreased appetite

  • difficulty swallowing

  • dilated neck veins

  • disturbed color perception

  • double vision

  • extreme fatigue

  • fast or irregular breathing

  • feeling of discomfort

  • general feeling of tiredness or weakness

  • halos around lights

  • hearing loss

  • hives or welts

  • increased sweating

  • inflammation of the joints

  • joint pain

  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs

  • loss of heat from the body

  • loss of vision

  • lower back or side pain

  • night blindness

  • overbright appearance of lights

  • painful or difficult urination

  • pale skin

  • pinpoint red spots on the skin

  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue

  • rapid weight gain

  • red skin lesions, often with a purple center

  • red, irritated eyes

  • red, swollen skin

  • scaly skin

  • sores, ulcers, or white spots on the lips or in the mouth

  • stomach pain, continuing

  • swollen lymph glands

  • tingling of the hands or feet

  • tunnel vision

  • unsteadiness or awkwardness

  • unusual bleeding or bruising

  • unusual weight gain or loss

  • upper right abdominal pain

  • weakness in the arms, hands, legs, or feet

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Decreased interest in sexual intercourse

  • difficulty having a bowel movement (stool)

  • difficulty in moving

  • discouragement

  • feeling of constant movement of self or surroundings

  • feeling sad or empty

  • inability to have or keep an erection

  • indigestion

  • irritability

  • loss in sexual ability, desire, drive, or performance

  • loss of interest or pleasure

  • muscle aching or stiffness

  • pain or tenderness around eyes and cheekbones

  • passing of gas

  • sensation of spinning

  • sleepiness or unusual drowsiness

  • soreness of the skin

  • stomach fullness or discomfort

  • stuffy or runny nose

  • swollen joints

  • tiredness

  • trouble concentrating

  • trouble sleeping

Rare
  • Acid or sour stomach

  • belching

  • change in taste

  • hair loss or thinning of the hair

  • heartburn

  • increased need to urinate

  • increased sensitivity of the eyes to sunlight

  • increased sensitivity of the skin to sunlight

  • loss of bladder control

  • loss of taste

  • menstrual changes

  • passing urine more often

  • redness or other discoloration of the skin

  • severe sunburn

  • stomach fullness, discomfort, or upset

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: itraconazole side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More itraconazole resources


  • Itraconazole Side Effects (in more detail)
  • Itraconazole Use in Pregnancy & Breastfeeding
  • Drug Images
  • Itraconazole Drug Interactions
  • Itraconazole Support Group
  • 11 Reviews for Itraconazole - Add your own review/rating


  • Itraconazole Prescribing Information (FDA)

  • Itraconazole Professional Patient Advice (Wolters Kluwer)

  • Itraconazole Monograph (AHFS DI)

  • Itraconazole MedFacts Consumer Leaflet (Wolters Kluwer)

  • Sporanox Consumer Overview

  • Sporanox Prescribing Information (FDA)

  • Sporanox PulsePak MedFacts Consumer Leaflet (Wolters Kluwer)



Compare itraconazole with other medications


  • Aspergillosis, Aspergilloma
  • Blastomycosis
  • Candida Infections, Systemic
  • Candida Urinary Tract Infection
  • Coccidioidomycosis
  • Cryptococcosis
  • Dermatophytosis
  • Esophageal Candidiasis
  • Febrile Neutropenia
  • Histoplasmosis
  • Onychomycosis, Fingernail
  • Onychomycosis, Toenail
  • Oral Thrush
  • Paracoccidioidomycosis
  • Sporotrichosis
  • Tinea Capitis
  • Tinea Versicolor
  • Vaginal Yeast Infection


Hemabate Sterile Solution





PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER



HEMABATE STERILE SOLUTION FOR INJECTION



Carboprost tromethamine 250mcg/ml




In this leaflet:



  • 1. What Hemabate Sterile Solution is and what it is used for

  • 2. Before you are given Hemabate Sterile Solution

  • 3. How you are given Hemabate Sterile Solution

  • 4. Possible side effects

  • 5. Storing Hemabate Sterile Solution

  • 6. Further information





What Hemabate Sterile Solution is and what it is used for



  • Hemabate is a sterile solution for injection. It is available in ampoules and contains 250mcg of the active ingredient, carboprost, per ml of solution.


  • Hemabate is used to stop excessive bleeding in women who have just given birth, when bleeding is due to the womb failing to return to its normal size.


  • Hemabate belongs to a group of medicines called prostaglandins. Prostaglandins are produced naturally in your body and are very important for a variety of activities, including childbirth. After childbirth they make the womb contract and to help it stay contracted, which stops heavy bleeding from the womb. Hemabate given after childbirth increases the contraction of your womb which helps to control bleeding after delivery.




Before you are given Hemabate Sterile Solution




Do not take Hemabate:



Hemabate is not suitable for all women. Your doctor may decide to give you a different medicine if any of these apply to you.





You should not be given Hemabate if you:



  • have ever had an allergic reaction to Hemabate or to any of the other ingredients of the medicine, in particular benzyl alcohol which can cause problems in some people – see Sections 4 and 6 of this leaflet for more details.


  • currently have an infection of your womb, ovaries or fallopian tubes (this may be causing pain in your pelvis or vaginal discharge).




Take special care with Hemabate:



Tell your doctor if you currently have, or have had in the past any of the following, as Hemabate will have to be used more carefully;



  • glaucoma (raised pressure in your eyes)

  • high or low blood pressure (including high blood pressure in pregnancy)

  • heart disease or anaemia (low blood count)

  • lung disease, including asthma

  • kidney or liver disease (including jaundice)

  • diabetes or epilepsy

  • a caesarean section or any other operation on your womb




Taking other medicines:



Treatments that strengthen contraction of the womb, including oxytocin and ergometrine, can be affected by Hemabate. Medical staff will watch over you very carefully if you have had these treatments as well as Hemabate.



Tell your midwife or doctor if you are taking any other medicines.





Pregnancy and Breastfeeding:



Hemabate will only be given shortly after you have delivered your baby and not while you are still pregnant.



It is not known if carboprost is excreted in human breast milk. As your own body produces prostaglandins during childbirth, Hemabate is not expected to cause any harm to your baby.





Driving and using machinery:



It is unlikely that you will be well enough to drive or operate machinery soon after receiving Hemabate. Make sure you are fully recovered before driving or doing any activity where you need to concentrate.





Important information about some of the ingredients of Hemabate



Hemabate contains less than 1 mmol sodium (23mg) per dose and is essentially ‘sodium free.’



Hemabate also contains benzyl alcohol which may cause allergic reactions.






How you are given Hemabate Sterile Solution



This product should be used only in hospitals and clinics with specialised units for pregnancy and childbirth. Medical staff should be available in the hospital at all times. Hemabate may be given by a doctor or a midwife.



The staff will make sure that this medicine is used in the right way and at the right time. You should never be given Hemabate while you are pregnant, only after the birth. It must never be given by injection into a vein.



  • Hemabate is given by injection deep into a muscle.


  • The first dose is usually 1 ml of solution (250 micrograms of carboprost). Your doctor may give you more doses of 1 ml if you need them. You should not have doses more often than once every 15 minutes. Usually you would have them less often, about once in one-and-a-half hours.


  • You should not be given more than 8 doses (2 mg of carboprost) altogether


What if I am given too much Hemabate?



If you get very bad sickness and diarrhoea, your doctor may delay the next injection of Hemabate, or may not give you any more doses. Your doctor will treat the symptoms that the Hemabate has caused





What if I continue to bleed?



If you continue to bleed heavily after being given Hemabate you may be given other medicines to help control the bleeding. Your doctor or midwife will be watching you closely to help them decide whether Hemabate is working for you.






Possible Side Effects



All medicines can cause side effects.



The following side effects occur occasionally after Hemabate treatment and can be serious, so it is important to bring these to the attention of medical staff straight away:



  • Effects on your respiratory system and immune system: Hemabate can very occasionally cause serious breathing difficulties as well as asthma and wheezing. If you have any difficulty breathing after receiving Hemabate tell your doctor or midwife immediately.


  • The benzyl alcohol in Hemabate solution can cause an allergic reaction in some people. If you suffer from wheezing together with any itching or swelling of the face or tongue tell your doctor or midwife immediately.


Other side effects seen with Hemabate include:



  • Effects on your heart and circulation: Hemabate may temporarily raise blood pressure and sometimes this can be dangerous if it gets very high. It can also suddenly lower blood pressure making you faint. Your doctor or midwife will be monitoring your blood pressure closely to look for signs of this. Some people treated with carboprost may develop low oxygen levels in their blood. It is still unclear whether this is caused by treatment with carboprost. If you develop low oxygen levels, it might make you feel dizzy. Your doctor can give you extra oxygen if this happens to you.


  • Effects on your stomach and intestines: The most common side effects with Hemabate are nausea (feeling sick), vomiting and diarrhoea. If these side effects are very bad, your doctor may give you other medicines to stop you being sick and to reduce the diarrhoea. They may also reduce or delay the next dose (also see ‘How you are given Hemabate’, above).


  • Effects on your metabolism Hemabate can cause you to experience changes in body temperature. You may feel hot, flushed and sweaty, or chilled and shivery. These effects usually wear off quickly after treatment.


  • Effects on skin: Hemabate can sometimes cause pain and redness around where you had your injection.



Most effects are mild and short-lived and will wear off quickly after treatment. If you feel very unwell or have any other unusual effects not listed above, tell your doctor at once.





Storing Hemabate Sterile Solution



Hemabate should not be used after the expiry date printed on the box and on the ampoule. Your pharmacist will check this before the injection is given.



Ampoules should be stored in a refrigerator between 2 – 8 °C. Your pharmacist will check the ampoules are still clear and colourless before use. As with all medicines they will be kept out of the sight and reach of children. .





Further Information




What Hemabate contains



The active substance in each ampoule is 250mcg of carboprost..



The other ingredients are sodium chloride (sodium content approximately 4.0mg/ml), water for injections , tromethamine and a preservative, benzyl alcohol (8.1 – 10.4 mg/ml). Small amounts of hydrochloric acid and sodium hydroxide, (used to regulate the acidity or alkalinity of the solution) may also be present.





What Hemabate looks like and contents of the pack



Hemabate is a colourless solution available in glass ampoules containing 1ml of solution. Hemabate comes in packs of two or ten ampoules.





Marketing Authorisation Holder:




Pharmacia Limited

Ramsgate Road

Sandwich

Kent

CT13 9NJ





Manufacturer:



Hemabate is made by




Pfizer Service Company BVBA

Zaventem

Belgium





Company contact address:



For further information on your medicine contact Medical Information at the following address:




Pfizer Limited

Walton Oaks

Dorking Road

Tadworth

Surrey

KT20 7NS

Telephone:01304 616161





Leaflet last updated: June 2008



Ref: HM_003







Pepto-Bismol Chewable Tablets





1. Name Of The Medicinal Product



Pepto-Bismol Chewable Tablets, 262.5mg/tablet


2. Qualitative And Quantitative Composition



ACTIVE INGREDIENT



Each tablet contains 262.5mg Bismuth subsalicylate



For excipients see 6.1



3. Pharmaceutical Form



Chewable Tablet



4. Clinical Particulars



4.1 Therapeutic Indications



For fast relief of upset stomach, indigestion, heartburn and nausea.



Controls diarrhoea.



4.2 Posology And Method Of Administration



Adults and children 16 years and over :



2 tablets



Repeat dose every 1/2 to 1 hour if needed. No more than 16 tablets to be taken in 24 hours.



One adult dose (2 tablets) contains 525mg of Bismuth Subsalicylate



Do not exceed the recommended dose.



Pepto-Bismol can be taken before or after meals, on either an empty or full stomach.



For oral use only.



4.3 Contraindications



Pepto-Bismol should not be used by patients hypersensitive to Aspirin or other salicylates.



Pepto-Bismol should not be used by patients hypersensitive to any ingredient in the formulation.



Pepto-Bismol should not be used by children under 16 years of age.



4.4 Special Warnings And Precautions For Use



Do not take with aspirin or other salicylates



Pepto-Bismol should not be used by those aged under 16 due to a possible association between salicylates and Reye's syndrome, a very rare but very serious disease



Caution should be exercised by patients taking medicines for anti-coagulation (thinning of the blood), diabetes or gout.



Pepto-Bismol should not be used if symptoms are severe or persist for more than 2 days.



Do not exceed the recommended dose.



Keep all medicines out of reach and sight of children.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



Pepto-Bismol contains salicylates therefore care should be exercised if receiving drugs to thin the blood (anticoagulant therapy) or therapy for diabetes or treatment for gout.



4.6 Pregnancy And Lactation



There are no adequate data concerning the use of Pepto-Bismol in pregnant women.



Animal studies are insufficient with respect to effects on pregnancy, embryonal/foetal development, parturition and postnatal development. The potential risk for humans is unknown.



Pepto-Bismol should not be used during pregnancy and lactation unless clearly necessary.



4.7 Effects On Ability To Drive And Use Machines



None.



4.8 Undesirable Effects



Black tongue is common (>1/100, <1/10) undesired effect, the undesired effect of black stool is very common (>1/10).



4.9 Overdose



Bismuth



Bismuth intoxication may present as an acute encephalopathy with confusion, myoclonic movements, tremor, dysarthria and walking and standing disorders. Bismuth intoxication may also cause gastrointestinal disturbances, skin reactions, discolouration of mucous membranes, and renal dysfunction as a result of acute tubular necrosis. Treatment includes gastric lavage, purgation and hydration. Chelating agents may be effective in the early stages following ingestion and haemodialysis may be necessary.



Salicylate



Overdose of Pepto-Bismol may also give symptoms of salicylate intoxification. Salicylate poisoning is usually associated with plasma concentrations>350 mg/L (2.5 mmol/L). Most adult deaths occur in patients whose concentrations exceed 700 mg/L (95.1 mmol/L). Single doses less than 100 mg/kg are unlikely to cause serious poisoning.



If symptoms occur, use of Pepto-Bismol should be discontinued. Management of overdose is the same as that for salicylate overdose:



Common features include vomiting, dehydration, tinnitus, vertigo, deafness, sweating, warm extremities with bounding pulses, increased respiratory rate and hyperventilation. Some degree of acid-base disturbance is present in most cases.



A mixed respiratory alkalosis and metabolic acidosis with normal or high arterial pH (normal or reduced hydrogen ion concentration) is usual in adults and children over the age of four years. In children aged four years or less, a dominant metabolic acidosis with low arterial pH (raised hydrogen ion concentration) is common. Acidosis may increase salicylate transfer across the blood brain barrier.



Uncommon features include haematemesis, hyperpyrexia, hypoglycaemia, hypokalaemia, thrombocytopaenia, increased INR/PTR, intravascular coagulation, renal failure and non-cardiac pulmonary oedema.



Central nervous system features including confusion, disorientation, coma and convulsions are less common in adults than in children.



Management: Give activated charcoal if an adult presents within one hour of ingestion of more than 250 mg/kg. The plasma salicylate concentration should be measured, although the severity of poisoning cannot be determined from this alone and the clinical and biochemical features must be taken into account. Elimination is increased by urinary alkalinisation, which is achieved by the administration of 1.26% sodium bicarbonate. The urine pH should be monitored. Correct metabolic acidosis with intravenous 8.4% sodium bicarbonate (first check serum potassium). Forced diuresis should not be used since it does not enhance salicylate excretion and may cause pulmonary oedema.



Haemodialysis is the treatment of choice for severe poisoning and should be considered in patients with plasma salicylate concentrations>700 mg/L (5.1 mmol/L), or lower concentrations associated with severe clinical or metabolic features. Patients under ten years or over 70 have increased risk of salicylate toxicity and may require dialysis at an earlier stage.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Pharmacotherapeutic code: ATC code A07B B



The demulcent base provides a protective coating of the lower oesophagus and a partial coating in the stomach which holds the bismuth subsalicylate in suspension.



Limited in vitro studies have shown BSS to have some activity against enteropathogens, ie Clostridium. Bacteroides, E. Coli, Salmonella Shigella, campoylobacter (Helicobacter) and Yersina, but not against anaerobes. There are insufficient data to determine whether these findings have any relevance to treatment outcomes in the patient population who may receive BSS.



5.2 Pharmacokinetic Properties



Bismuth subsalicylate is converted to bismuth carbonate and sodium salicylate in the small intestine.



The oral bioavailability of bismuth administered as Bismuth subsalicylate is extremely low. Very little is known about bismuth distribution in human tissue. Renal clearance is the primary route of elimination for absorbed bismuth, however biliary clearance may also have a role. The remainder is eliminated as insoluble bismuth salts in the faeces. Following the maximum recommended daily adult dose, the mean biological half-life is approximately 33 hours and peak plasma bismuth levels remain below 35ppb.



Salicylate is absorbed from the intestine and rapidly distributed to all body tissues. Peak plasma levels after maximum recommended daily dosing are about 110 micrograms/ml. Salicylate is rapidly excreted from the body and has a mean biological half life of approximately 4 - 5.5 hours.



5.3 Preclinical Safety Data



There are no pre-clinical safety data of relevance to health professionals, other than those already included in other sections of the SPC



6. Pharmaceutical Particulars



6.1 List Of Excipients



Mannitol



Calcium carbonate



Povidone



Magnesium stearate



Talc



Peppermint flavour



Saccharin sodium



Aspartame



Amaranth, aluminium lake (E123)



Vanilla cream flavour



6.2 Incompatibilities



None stated.



6.3 Shelf Life



36 months



6.4 Special Precautions For Storage



Do not store above 25oC.



6.5 Nature And Contents Of Container



12 or 24 tablets in a cellophane film, packed in an outer claycoat board carton



6.6 Special Precautions For Disposal And Other Handling



None



7. Marketing Authorisation Holder



Procter & Gamble (Health & Beauty Care) Limited



Rusham Park



Whitehall Lane



Egham



Surrey



TW20 9NW



8. Marketing Authorisation Number(S)



PL 0129/0143



9. Date Of First Authorisation/Renewal Of The Authorisation



13/07/2005



10. Date Of Revision Of The Text



June 2004





Friday, October 28, 2016

Boots Sore Throat Relief Dual Action Lozenges Black Cherry Flavour






Boots Sore Throat Relief Dual Action Lozenges Black Cherry Flavour



(Hexylresorcinol)



Antiseptic and local anaesthetic



Fights infection



Effective relief from sore throat pain



24, 36 Pack



Read all of this carton for full instructions.




What this medicine is for


This medicine contains an antiseptic, which combats the bacteria that causes a sore throat, and has a local anaesthetic effect, which brings soothing relief of pain and discomfort. It can be used for effective relief of sore throats.




Before you take this medicine



Do not take:



  • If you are allergic to any of the ingredients


  • If you have an intolerance to some sugars, unless your doctor tells you to (this medicine contains glucose and sucrose)



Talk to your pharmacist or doctor:


  • If you are pregnant or breastfeeding


Information about some of the ingredients: Each lozenge contains a total of 2.4 g of glucose and sucrose. This should be taken into account by people with diabetes. The colour E122 in this medicine may cause allergic reactions.




How to take this medicine


Check the foil is not broken before use. If it is, do not take that lozenge.




Adults and children of 6 years and over: Suck one lozenge every 3 hours, or when you need to.



Don’t take more than 12 lozenges in any 24 hours.



Suck each lozenge slowly until it dissolves.


Do not give to children under 6 years.


Do not take more than the amount recommended.


If symptoms do not go away, talk to your doctor.



If you take too many lozenges: Talk to a pharmacist or doctor straight away.




Possible side effects


Most people will not have problems, but some may get some.



If you get any of these serious side effects, stop taking the lozenges. See a doctor at once:


  • Difficulty in breathing, swelling of the face, neck, tongue or throat (severe allergic reactions)



These other effects are less serious. If they bother you talk to a pharmacist:


  • Sore tongue



If any side effect becomes severe, or if you notice any side effect not listed here, please tell your pharmacist or doctor.




How to store this medicine


Do not store above 25°C.


Store in the original package.



Keep all medicines out of the sight and reach of children.


Use by the date on the end flap of the carton.




Active ingredient


Each lozenge contains Hexylresorcinol 2.4 mg


Also contains: sucrose, glucose syrup, cherry flavour, menthol, carmoisine (E122).


PL 00094/0038


Text prepared 7/09



Manufactured for



The Boots Company Plc

Nottingham

NG2 3AA




by The Marketing Authorisation holder



Ernest Jackson and Co Ltd

Crediton

Devon

EX17 3AP



If you need more advice ask your pharmacist.







Galantamine Solution



Pronunciation: gal-AN-ta-meen
Generic Name: Galantamine
Brand Name: Razadyne


Galantamine Solution is used for:

Treating mild to moderate dementia (eg, impairment of memory or judgement, abstract thinking, changes in personality) in patients with Alzheimer disease.


Galantamine Solution is a cholinesterase inhibitor. It works by increasing the amount of a certain substance (acetylcholine) in the brain, which may help reduce symptoms of dementia in patients with Alzheimer disease.


Do NOT use Galantamine Solution if:


  • you are allergic to any ingredient in Galantamine Solution

  • you have severely decreased liver or kidney function

Contact your doctor or health care provider right away if any of these apply to you.



Before using Galantamine Solution:


Some medical conditions may interact with Galantamine Solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of liver or kidney problems, certain heart problems (eg, slow or irregular heartbeat, sick sinus syndrome), stomach or bowel problems (eg, ulcer, blockage), lung or breathing problems (eg, asthma, chronic obstructive pulmonary disease [COPD]), or urinary blockage

  • if you have brain lesions or tumors, increased pressure in the brain, recent head injury, or a history of seizures (eg, epilepsy)

  • if you have dementia or other decreased mental ability that is not caused by Alzheimer disease

Some MEDICINES MAY INTERACT with Galantamine Solution. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen) because the risk of stomach or bowel bleeding may be increased

  • Cholinergic agents (eg, bethanechol), cholinesterase inhibitors (eg, donepezil), ketoconazole, or serotonin specific reuptake inhibitors (eg, paroxetine) because they may increase the risk of Galantamine Solution's side effects

  • Anticholinergics (eg, scopolamine) because their effectiveness may be decreased by Galantamine Solution

This may not be a complete list of all interactions that may occur. Ask your health care provider if Galantamine Solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Galantamine Solution:


Use Galantamine Solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • An extra patient leaflet is available with Galantamine Solution. Talk to your pharmacist if you have questions about this information.

  • Take Galantamine Solution by mouth with morning and evening meals, unless otherwise directed by your doctor.

  • Use the measuring device that comes with Galantamine Solution to measure your dose. Ask your pharmacist for help if you are unsure of how to measure your dose.

  • After you have measured the dose, empty all of the medicine into 3 to 4 oz (100 mL) of any non-alcoholic drink. Stir well, the drink the mixture right away.

  • After use, rinse the measuring device. This is done by inserting it into a glass of water, pulling the plunger out, and then pushing the plunger back in to remove the water.

  • Drinking extra fluids while you are taking Galantamine Solution is recommended. Check with your doctor for instructions.

  • Take Galantamine Solution on a regular schedule to get the most benefit from it.

  • Taking Galantamine Solution at the same time each day will help you remember to take it.

  • Continue to take Galantamine Solution even if you feel well. Do not miss any doses.

  • If you miss a dose of Galantamine Solution, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once. Contact your doctor if you miss several doses of Galantamine Solution. Your doctor may need to restart your medicine at a lower dose to avoid side effects.

Ask your health care provider any questions you may have about how to use Galantamine Solution.



Important safety information:


  • Galantamine Solution may cause dizziness, drowsiness, or fainting. These effects may be worse if you take it with alcohol or certain medicines. Use Galantamine Solution with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not take more than the recommended dose without checking with your doctor.

  • When you begin taking Galantamine Solution, your doctor will increase your dose slowly over several months. This may help to decrease the risk of certain side effects (eg, nausea, vomiting, diarrhea). Carefully follow the dosing schedule prescribed by your doctor.

  • Tell your doctor or dentist that you take Galantamine Solution before you receive any medical or dental care, emergency care, or surgery.

  • Galantamine Solution should not be used in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Galantamine Solution while you are pregnant. It is not known if Galantamine Solution is found in breast milk. Galantamine Solution is not indicated for use in women who may be breast-feeding.


Possible side effects of Galantamine Solution:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Diarrhea; dizziness; headache; loss of appetite; nausea; stomach upset; tiredness; vomiting; weight loss.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bloody, black, or tarry stools; chest pain; decreased urination; depression; fainting; fever; seizures; severe or persistent tiredness or weakness; slow or irregular heartbeat; tremor.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Galantamine side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include fainting; increased sweating or saliva production; loss of bowel control; loss of consciousness; muscle weakness; seizures; severe dizziness; severe nausea or vomiting; slow heartbeat; slow or shallow breathing; stomach cramping.


Proper storage of Galantamine Solution:

Store Galantamine Solution at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Do NOT freeze. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Galantamine Solution out of the reach of children and away from pets.


General information:


  • If you have any questions about Galantamine Solution, please talk with your doctor, pharmacist, or other health care provider.

  • Galantamine Solution is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Galantamine Solution. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Galantamine resources


  • Galantamine Side Effects (in more detail)
  • Galantamine Dosage
  • Galantamine Use in Pregnancy & Breastfeeding
  • Drug Images
  • Galantamine Drug Interactions
  • Galantamine Support Group
  • 5 Reviews for Galantamine - Add your own review/rating


Compare Galantamine with other medications


  • Alzheimer's Disease


Guaifenesin/Hydrocodone Sustained-Release Tablets


Pronunciation: gwye-FEN-e-sin/hye-droe-KOE-done
Generic Name: Guaifenesin/Hydrocodone
Brand Name: Tusso-HC


Guaifenesin/Hydrocodone Sustained-Release Tablets are used for:

Relieving cough and throat and airway irritation due to colds, flu, or hay fever. It may also be used for other conditions as determined by your doctor.


Guaifenesin/Hydrocodone Sustained-Release Tablets are a cough suppressant and expectorant combination. It works by loosening mucus and lung secretions in the chest, and making coughs more productive. The cough suppressant works in the brain to help decrease the cough reflex to reduce a dry cough.


Do NOT use Guaifenesin/Hydrocodone Sustained-Release Tablets if:


  • you are allergic to any ingredient in Guaifenesin/Hydrocodone Sustained-Release Tablets or any other codeine or morphine-related medicine (eg, oxycodone)

  • you are taking sodium oxybate (GHB)

  • you have increased pressure in the brain, trouble breathing, or diarrhea due to antibiotic use

Contact your doctor or health care provider right away if any of these apply to you.



Before using Guaifenesin/Hydrocodone Sustained-Release Tablets:


Some medical conditions may interact with Guaifenesin/Hydrocodone Sustained-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of glaucoma, an enlarged prostate gland or other prostate problems, heart problems, diabetes, high blood pressure, blood vessel problems, stroke, adrenal gland problems, or an underactive thyroid

  • if you have a history of stomach problems, bowel problems (eg, chronic inflammation or ulceration of the bowel), or gallbladder problems (eg, gallstones), or if you have had recent abdominal surgery

  • if you have breathing or lung problems (eg, asthma, chronic bronchitis, emphysema), or chronic obstructive pulmonary disease (COPD), or if cough occurs with large amounts of mucus

  • if you have recently had any head injury, brain injury or tumor, infection of the brain or nervous system, epilepsy, or seizures

  • if you have a history of alcohol abuse, drug abuse, or suicidal thoughts or behavior

Some MEDICINES MAY INTERACT with Guaifenesin/Hydrocodone Sustained-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Cimetidine because it may increase the risk of Guaifenesin/Hydrocodone Sustained-Release Tablets's side effects

  • Barbiturates (eg, phenobarbital) or sodium oxybate ( GHB) because the risk of severe drowsiness or breathing problems may be increased

  • Naltrexone because it may decrease Guaifenesin/Hydrocodone Sustained-Release Tablets's effectiveness

This may not be a complete list of all interactions that may occur. Ask your health care provider if Guaifenesin/Hydrocodone Sustained-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Guaifenesin/Hydrocodone Sustained-Release Tablets:


Use Guaifenesin/Hydrocodone Sustained-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Guaifenesin/Hydrocodone Sustained-Release Tablets by mouth with or without food.

  • Swallow Guaifenesin/Hydrocodone Sustained-Release Tablets whole. Do not break, crush, or chew before swallowing.

  • Drink plenty of water while taking Guaifenesin/Hydrocodone Sustained-Release Tablets.

  • If you miss a dose of Guaifenesin/Hydrocodone Sustained-Release Tablets, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Guaifenesin/Hydrocodone Sustained-Release Tablets.



Important safety information:


  • Guaifenesin/Hydrocodone Sustained-Release Tablets may cause dizziness or drowsiness. These effects may be worse if you take it with alcohol or certain medicines. Use Guaifenesin/Hydrocodone Sustained-Release Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.

  • If your symptoms do not bet better within 5 to 7 days or if they get worse, check with your doctor.

  • Guaifenesin/Hydrocodone Sustained-Release Tablets may interfere with certain lab tests. Be sure your doctor and lab personnel know you are taking Guaifenesin/Hydrocodone Sustained-Release Tablets.

  • Tell your doctor or dentist that you take Guaifenesin/Hydrocodone Sustained-Release Tablets before you receive any medical or dental care, emergency care, or surgery.

  • Use Guaifenesin/Hydrocodone Sustained-Release Tablets with caution in the ELDERLY; they may be more sensitive to its effects.

  • Guaifenesin/Hydrocodone Sustained-Release Tablets should not be used in CHILDREN younger than 6 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Guaifenesin/Hydrocodone Sustained-Release Tablets while you are pregnant. It is not known if Guaifenesin/Hydrocodone Sustained-Release Tablets are found in breast milk. Do not breast-feed while taking Guaifenesin/Hydrocodone Sustained-Release Tablets.


Possible side effects of Guaifenesin/Hydrocodone Sustained-Release Tablets:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; dizziness; drowsiness; excitability; headache; nausea; nervousness or anxiety; trouble sleeping; weakness.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); anxiety; change in amount of urine; difficulty urinating; hearing change or loss; mental or mood changes; severe drowsiness.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Guaifenesin/Hydrocodone side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.


Proper storage of Guaifenesin/Hydrocodone Sustained-Release Tablets:

Store Guaifenesin/Hydrocodone Sustained-Release Tablets at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Guaifenesin/Hydrocodone Sustained-Release Tablets out of the reach of children and away from pets.


General information:


  • If you have any questions about Guaifenesin/Hydrocodone Sustained-Release Tablets, please talk with your doctor, pharmacist, or other health care provider.

  • Guaifenesin/Hydrocodone Sustained-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Guaifenesin/Hydrocodone Sustained-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Guaifenesin/Hydrocodone resources


  • Guaifenesin/Hydrocodone Side Effects (in more detail)
  • Guaifenesin/Hydrocodone Use in Pregnancy & Breastfeeding
  • Guaifenesin/Hydrocodone Drug Interactions
  • Guaifenesin/Hydrocodone Support Group
  • 2 Reviews for Guaifenesin/Hydrocodone - Add your own review/rating


Compare Guaifenesin/Hydrocodone with other medications


  • Cough


Beechams Flu-Plus Hot Berry Fruits





1. Name Of The Medicinal Product



Beechams Flu-Plus Hot Berry Fruits


2. Qualitative And Quantitative Composition












Active Constituents




mg / 6.427 g powder




Paracetamol




1000




Ascorbic Acid




70




Phenylephrine Hydrochloride




10



3. Pharmaceutical Form



Powder



4. Clinical Particulars



4.1 Therapeutic Indications



Short term symptomatic relief of symptoms of influenza, feverishness, chills and colds including headache, sore throat pain, aches and pains, nasal congestion, sinusitis and its associated pain, and acute nasal catarrh.



4.2 Posology And Method Of Administration



Directions for use



Empty contents of sachet into a beaker. Half fill with very hot water. Stir well. Add cold water as necessary and sugar if desired.



Recommended Dose and Dosage Schedule



Adults (including elderly) and children aged 12 years and over:



The contents of one sachet to be taken every four to six hours as necessary, up to a maximum of four sachets in any 24 hours.



The product should not be used continuously for more than seven days without medical advice.



Not to be given to children under 12 years of age, except on medical advice.



4.3 Contraindications



Known hypersensitivity to paracetamol or any of the other constituents.



Concomitant use of other sympathomimetic decongestants



Phaeochromocytoma



Closed angle glaucoma



Hepatic or severe renal impairment, hypertension, hyperthyroidism, diabetes, heart disease. Patients taking tricyclic antidepressants or beta-blocking drugs and those patients who are taking or have taken within the last two weeks, monoamine oxidase inhibitors (see section 4.5).



4.4 Special Warnings And Precautions For Use



Care is advised in the administration of paracetamol to patients with severe renal or severe hepatic impairment. The hazard of overdose is greater in those with non-cirrhotic alcoholic liver disease.



Medical advice should be sought before taking this product in patients with these conditions:



• An enlargement of the prostate gland



• Occulusive Vascular disease (e.g. Raynaud's Phenomenon)



• Cardiovascular disease



This product should not be used by patients taking other sympathomimetics (such as decongestants, appetite suppressants and amphetamine-like psychostimulants).



Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.



Do not exceed the stated dose.



Do not take with any other paracetamol-containing products. Do not take with other flu, cold or decongestant products.



Keep out of the reach and sight of children.



If symptoms persist consult your doctor.



Consult your doctor if you are taking warfarin.



Special label warnings



Do not take with any other paracetamol-containing products. Do not take with other flu, cold or decongestant products.



Immediate medical advice should be sought in the event of an overdose, even if you feel well.



Special leaflet warnings



Immediate medical advice should be sought in the event of an overdose, even if you feel well, because of the risk of delayed, serious liver damage.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



The speed of absorption of paracetamol may be increased by metoclopramide or domperidone and absorption reduced by colestyramine. The anticoagulant effect of warfarin and other coumarins may be enhanced by prolonged regular daily use of paracetamol with increased risk of bleeding, occasional doses have no significant effect.



Phenylephrine should be used with caution in combination with the following drugs as interactions have been reported
















Monoamine oxidase inhibitors



(including moclobemide)




Hypertensive interactions occur between sympathomimetic amines such as phenylephrine and monoamine oxidase inhibitors (see contraindications).




Sympathomimetic amines




Concomitant use of phenylephrine with other sympathomimetic amines can increase the risk of cardiovascular side effects.




Beta-blockers and other antihypertensives (including debrisoquine, guanethidine, reserpine, methyldopa)




Phenylephrine may reduce the efficacy of beta-blocking drugs and antihypertensive drugs. The risk of hypertension and other cardiovascular side effects may be increased.




Tricyclic antidepressants (e.g. amitriptyline)




May increase the risk of cardiovascular side effects with phenylephrine.




Ergot alkaloids




(ergotamine and methylsergide) increased risk of ergotism




Digoxin and cardiac glycosides




Increase the risk of irregular heartbeat or heart attack



4.6 Pregnancy And Lactation



Due to the phenylephrine content this product should not be used in pregnancy or whilst breast-feeding without medical advice. Phenylephrine may be excreted in breast milk.



4.7 Effects On Ability To Drive And Use Machines



Patients should be advised not to drive or operate machinery if affected by dizziness.



4.8 Undesirable Effects



Paracetamol



Adverse events from historical clinical trial data are both infrequent and from small patient exposure. Accordingly, events reported from extensive post-marketing experience at therapeutic/labelled dose and considered attributable are tabulated below by system class. Due to limited clinical trial data, the frequency of these adverse events is not known (cannot be estimated from available data), but post-marketing experience indicates that adverse reactions to paracetamol are rare and serious reactions are very rare.














Body System




Undesirable effect




Blood and lymphatic system disorders




Thrombocytopenia



Agranulocytosis



These are not necessarily casually related to paracetamol.




Immune system disorders




Anaphylaxis



Cutaneous hypersensitivity reactions including skin rashes, angiodema and Stevens Johnson syndrome/toxic epidermal necrolysis




Respiratory, thoracic and mediastinal disorders




Bromchospasm*




Hepatobiliary disorders




Hepatic dysfunction



* There have been cases of bronchospasm with paracetamol, but these are more likely in asthmatics sensitive to aspirin or other NSAIDs.



Phenylephrine



The following adverse events have been observed in clinical trials with phenylephrine and may therefore represent the most commonly occurring adverse events.














Body System




Undesirable effect




Psychiatric disorders




Nervousness, irritability, restlessness, and excitability




Nervous system disorders




Headache, dizziness, insomnia




Cardiac disorders




Increased blood pressure




Gastrointestinal disorders




Nausea, Vomiting, diarrhoea



Adverse reactions identified during post-marketing use are listed below. The frequency of these reactions is unknown but likely to be rare.












Eye disorders




Mydriasis, acute angle closure glaucoma, most likely to occur in those with closed angle glaucoma




Cardiac disorders




Tachycardia, palpitations




Skin and subcutaneous disorders




Allergic reactions (e.g. rash, urticaria, allergic dermatitis).



Hypersensitivity reactions – including that cross-sensitivity may occur with other sympathomimetics




Renal and urinary disorders




Dysuria, urinary retention. This is most likely to occur in those with bladder outlet obstruction, such as prostatic hypertrophy.



4.9 Overdose



Paracetamol



Liver damage is possible in adults who have taken 10 g or more of paracetamol. Ingestion of 5 g or more of paracetamol may lead to liver damage if the patient has risk factors (see below).



Risk factors



If the patient



a) Is on long term treatment with carbamazepine, phenobarbitone, phenytoin, primidone, rifampicin, St John's Wort or other drugs that induce liver enzymes.



or



b) Regularly consumes ethanol in excess of recommended amounts.



or



c) Is likely to be glutathione deplete e.g. eating disorders, cystic fibrosis, HIV infection, starvation, cachexia.



Symptoms



Symptoms of paracetamol overdose in the first 24 hours are pallor, nausea, vomiting, anorexia and abdominal pain. Liver damage may become apparent 12 to 48 hours after ingestion. Abnormalities of glucose metabolism and metabolic acidosis may occur. In severe poisoning, hepatic failure may progress to encephalopathy, haemorrhage, hypoglycaemia, cerebral oedema and death. Acute renal failure with acute tubular necrosis, strongly suggested by loin pain, haematuria and proteinuria, may develop even in the absence of severe liver damage. Cardiac arrythmias and pancreatitis have been reported.



Management



Immediate treatment is essential in the management of paracetamol overdose. Despite a lack of significant early symptoms, patients should be referred to hospital urgently for immediate medical attention. Symptoms may be limited to nausea or vomiting and may not reflect the severity of the overdose or the risk of organ damage. Management should be in accordance with established treatment guidelines, see BNF overdose section.



Treatment with activated charcoal should be considered if the overdose has been taken within 1 hour. Plasma paracetamol concentration should be measured at 4 hours or later after ingestion (earlier concentrations are unreliable). Treatment with N-acetylcysteine may be used up to 24 hours after ingestion of paracetamol, however, the maximum protective effect is obtained up to 8 hours post-ingestion. The effectiveness of the antidote declines sharply after this time. If required the patient should be given intravenous N-acetylcysteine, in line with the established dosage schedule. If vomiting is not a problem, oral methionine may be a suitable alternative for remote areas outside hospital. Management of patients who present with serious hepatic dysfunction beyond 24 h from ingestion should be discussed with the NPIS or a liver unit.



Phenylephrine



Symptoms and signs



Phenylephrine overdosage is likely to result in effects similar to those listed under adverse reactions. Additional symptoms may include hypertension and possibly reflux bradycardia. In severe cases confusion, hallucinations, seizures and arrythmias may occur. However the amount required to produce serious phenylephrine toxicity would be greater than required to cause paracetamol-related toxicity.



Treatment



Treatment should be as clinically appropriate. Severe hypertension may need to be treated with an alpha blocking drug such as phentolamine.



Ascorbic acid



Symptoms and signs



High doses of ascorbic acid (>3000 mg) may cause transient osmotic diarrhoea and gastrointestinal effects such as nausea and abdominal discomfort. Effects of overdose of ascorbic acid would be subsumed by severe liver toxicity caused by paracetamol overdose.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Paracetamol: An analgesic and antipyretic.



Ascorbic acid: a common ingredient of cold and influenza combination products included to compensate for Vitamin C losses which may occur in the initial stages of acute viral infections.



Phenylephrine hydrochloride: a sympathomimetic decongestant.



The active ingredients are not known to cause sedation.



5.2 Pharmacokinetic Properties



Paracetamol: is readily absorbed from the gastrointestinal tract. It is metabolised in the liver and excreted in the urine, mainly as glucoronide and sulphate conjugates.



Ascorbic Acid: is readily absorbed from the gastrointestinal tract and is widely distributed in the body tissues, 25% bound to plasma proteins. Ascorbic Acid in excess of the body's needs is eliminated in the urine as metabolites.



Phenylephrine Hydrochloride: is readily absorbed from the gastrointestinal tract and undergoes first-pass metabolism by monoamine oxidase in the gut and liver; orally administered phenylephrine thus has reduced bioavailability. It is excreted in the urine almost entirely as the sulphate conjugate.



5.3 Preclinical Safety Data



There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Tartaric acid, Sodium citrate, Aspartame (E951), Euroblend blackcurrant, Berry fruit flavourburst, Sucrose and colours carmoisine (E122) and sunset yellow (E110) , green S (E142) with sodium chloride and sodium sulphate.



6.2 Incompatibilities



None known



6.3 Shelf Life



Three years



6.4 Special Precautions For Storage



Do not store above 25°C.



6.5 Nature And Contents Of Container



The product is packed in laminate sachets comprising paper/polythene/aluminium foil/polythene. Five or ten sachets may be contained in a box board carton.



6.6 Special Precautions For Disposal And Other Handling



Not applicable.



7. Marketing Authorisation Holder



Beecham Group Plc



980 Great West Road



Brentford



Middlesex



TW8 9GS



United Kingdom



Trading as: GlaxoSmithKline Consumer Healthcare, Brentford, TW8 9GS, U.K.



8. Marketing Authorisation Number(S)



PL 00079/0336



9. Date Of First Authorisation/Renewal Of The Authorisation



July 1996



10. Date Of Revision Of The Text



June 2010